Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

255
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
255
Visual Agnosia01:12

Visual Agnosia

482
Visual agnosia is a condition characterized by the inability to recognize visually presented objects despite having normal vision. For instance, a person with visual agnosia can describe the shape and color of an object but cannot identify or name it. This impairment does not affect their visual field, acuity, color vision, brightness discrimination, language, or memory. An example of this condition in a social setting is someone at a dinner party asking for "that silver thing with a round...
482
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

877
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
877
Prosopagnosia01:24

Prosopagnosia

408
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
408
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

416
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
416
Dissociative Amnesia01:21

Dissociative Amnesia

215
Dissociative amnesia is a complex psychological condition that manifests as an inability to recall personal information, often tied to traumatic or stressful events. Unlike general amnesia, individuals with this condition retain the ability to perform routine activities and procedural tasks, such as operating a phone or navigating public transportation, yet experience profound gaps in autobiographical memory. These lapses may encompass significant life events, such as suicide attempts or...
215

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impacts of menopausal hormone therapy on Alzheimer's disease biomarkers: A systematic review.

Journal of Alzheimer's disease : JAD·2026
Same author

Methodological considerations on the network meta-analysis of brexpiprazole dosing for agitation in Alzheimer's disease.

Journal of Alzheimer's disease : JAD·2026
Same author

Causes of death in patients with dementia: A study in a geriatric hospital in São Paulo, Brazil.

Journal of Alzheimer's disease : JAD·2026
Same author

Portable eye-tracking in neurology: current uses and future perspectives in cognition.

Arquivos de neuro-psiquiatria·2026
Same author

In Memoriam: Cesar Noronha Raffin.

Arquivos de neuro-psiquiatria·2025
Same author

Collateral Status Evaluation Using CT Angiography and Perfusion Source Images in Acute Stroke Patients.

Brain sciences·2025

Related Experiment Video

Updated: Oct 25, 2025

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.0K

Misoplegia and dementia: a case study.

Diogo Haddad Santos1,2, Yngrid Dieguez Ferreira1,2, Gilvan Guersoni Hora1

  • 1Irmandade da Santa Casa de Misericórdia de São Paulo - São Paulo, SP, Brazil.

Dementia & Neuropsychologia
|August 4, 2021
PubMed
Summary

Misoplegia, a condition causing aversion to an impaired limb, is rare. This case report details a patient with misoplegia and vascular dementia, highlighting the need for more research into this unusual neurological deficit.

Keywords:
dementiamental disordersneurodegenerative diseaseself-injurious behavior

More Related Videos

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.3K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.7K

Related Experiment Videos

Last Updated: Oct 25, 2025

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.0K
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.3K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.7K

Area of Science:

  • Neurology
  • Psychiatry
  • Neuropsychology

Background:

  • Brain damage can lead to unusual psychological responses to physical deficits.
  • Misoplegia is characterized by intense aversion and hostility towards an affected limb.
  • Existing literature on misoplegia is limited, necessitating case reports for better understanding.

Observation:

  • The case involves a patient diagnosed with vascular dementia.
  • The patient exhibited symptoms consistent with misoplegia, including exaggerated aversion to an impaired limb.
  • Behavioral manifestations included hatred of paresis and directed abuse towards the paretic limb.

Findings:

  • This report presents a rare case of misoplegia co-occurring with vascular dementia.
  • The patient's presentation underscores the complex interplay between cognitive decline and psychological disturbances post-brain injury.
  • The case highlights the potential for misoplegia to manifest in neurodegenerative conditions.

Implications:

  • Further research is needed to explore the pathophysiology and prevalence of misoplegia.
  • Understanding misoplegia in dementia patients can improve patient care and therapeutic strategies.
  • This case contributes to the limited body of knowledge on misoplegia, aiding in diagnosis and management.